Prudential PLC Seagen Inc. Transaction History

Prudential PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$191.51 - $216.16 $163,741 - $184,816	-855 Reduced 15.81%	4,553 $965,000
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $562 - $618	3 Added 0.06%	5,408 $1.04 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $29,600 - $47,114	-232 Reduced 4.12%	5,405 $1.09 Million
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $396,241 - $469,837	3,376 Added 149.31%	5,637 $724,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $42,880 - $57,094	317 Added 16.31%	2,261 $309,000

Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $15,342 - $25,285	-141 Reduced 6.76%	1,944 $344,000
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $249,386 - $329,117	2,085 New	2,085 $300,000
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $1.87 Million - $2.51 Million	-13,147 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$142.45 - $169.82 $141,167 - $168,291	-991 Reduced 7.01%	13,147 $2.23 Million
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $179,791 - $214,424	-1,331 Reduced 8.6%	14,138 $2.23 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $1.05 Million - $1.45 Million	-7,620 Reduced 33.0%	15,469 $2.15 Million
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $3.8 Million - $4.89 Million	23,089 New	23,089 $4.04 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.